Black Pepper for Health & Longevity - Quick Reference Sheet

Black Pepper for Health & Longevity

Created on 06/25/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Black pepper's health relevance comes almost entirely from one compound, piperine. Its clearest, most reliable effect is boosting how much of certain other compounds—above all turmeric's curcumin—reaches the bloodstream. Broader benefits for cholesterol, inflammation, and blood sugar almost always test piperine combined with curcumin, leaving its own contribution uncertain. The same property is also its main risk. (Full Review)

Protocol

Standard Protocol
~20 mg piperine with ~2,000 mg curcumin
Most evidence-aligned use; many products use ~5 mg BioPerine per dose
Timing
With partner compound and a fat-containing meal
Both piperine and curcumin absorb better with dietary fat; time of day not critical
Dosing Pattern
Split to accompany each dose of the partner compound
Short enzyme-inhibiting effect makes co-presence with each dose matter
Time to effect
Absorption Enhancement
Immediate
Peak curcumin enhancement seen within about an hour
Lipid & Downstream Changes
Weeks to months
Accrue over consistent combination use

Benefits

Contraindications
  • Pregnant or breastfeeding individuals
  • People scheduled for surgery within ~1–2 weeks
  • Those on narrow-therapeutic-index drugs (carbamazepine, cyclosporine, warfarin)
  • Active peptic ulcer disease or severe gastritis
Key Interactions
  • Prescription drugs (CYP3A4 substrates: simvastatin, calcium-channel blockers, cyclosporine, carbamazepine)
  • Anticoagulant/antiplatelet medications (warfarin, clopidogrel, aspirin)
  • Over-the-counter medications (ibuprofen, diclofenac, glucuronidated OTC agents)
  • Supplement interactions (CoQ10, curcumin, resveratrol, beta-carotene, selenium, vitamin B6)
  • Supplements with additive effects (curcumin, fish oil, plant sterols)

Risk & Side Effects

  • High: Drug and supplement interactions via enzyme inhibition
  • Medium: Gastrointestinal irritation
  • Low: Increased bleeding risk
  • Speculative: Reproductive and developmental concerns; reduced absorption in edge cases

Monitoring

Marker Target Why
Triglycerides < 100 mg/dL Tracks the main lipid benefit of curcumin-piperine
Total & LDL cholesterol LDL < 100 mg/dL (lower if high-risk) Captures lipid-lowering effect
HDL cholesterol > 50 mg/dL (women), > 40 mg/dL (men) May rise modestly with the combination
hs-CRP < 1.0 mg/L General marker of inflammation that the combination may lower
Fasting glucose 70–85 mg/dL Tracks any glycemic effect in metabolic users
ALT / AST ALT < 25 U/L (women), < 30 U/L (men) Liver enzymes; baseline matters because piperine inhibits liver clearance of drugs

Cadence: Baseline before starting, then ~8–12 weeks after starting, then every 6–12 months (more frequent if interacting medications are involved)

Qualitative Assessment

  • Improved digestion or comfort when the targeted partner compound is the reason for use
  • Subjective reduction in joint or inflammatory discomfort (if curcumin is the partner compound)
  • Absence of new GI irritation or unexpected medication side effects (a sign interactions are not occurring)
  • General energy and well-being trends over the monitoring window